Board member Cecily Mistarz adds RJF (RJF) stock via grants and RSU exercises

Rhea-AI Filing Summary

RAYMOND JAMES FINANCIAL INC director Cecily Mistarz reported equity-based compensation and related conversions on 2026-02-19. She acquired Restricted Stock Units through grants and exercised other RSUs that convert into common stock on a one-to-one basis with additional cash in lieu of dividends.

The transactions included a grant of 1,303 shares of common stock as part of compensation for Board service and multiple RSU awards and exercises at a reported price of $0.0000 per unit or share. Deferred Restricted Stock Units vest at the next annual shareholders meeting and, per her election, some will settle two years after vesting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mistarz Cecily

(Last) (First) (Middle)

880 CARILLON PARKWAY

(Street)

ST. PETERSBURG FL 33716

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RAYMOND JAMES FINANCIAL INC [ RJF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		A		1,303(1)	A	$0.0000	2,489(2)	D
Common Stock	02/19/2026		M		1,253	A	$0(3)	3,742(2)	D
Common Stock	02/19/2026		M		250	A	$0(3)	3,992(2)	D
Common Stock	02/19/2026		M		250	A	$0(3)	4,242(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	02/19/2026		A		248		(4)	(4)	Common Stock	248	$0.0000	2,001	D
Restricted Stock Units	(3)	02/19/2026		A		248		(4)	(4)	Common Stock	248	$0.0000	2,249	D
Restricted Stock Units	(3)	02/19/2026		M			250	(5)	(5)	Common Stock	250	$0.0000	1,999	D
Restricted Stock Units	(3)	02/19/2026		M			250	(5)	(5)	Common Stock	250	$0.0000	1,749	D
Restricted Stock Units	(3)	02/19/2026		M			1,253	(5)	(5)	Common Stock	1,253	$0.0000	496	D

Explanation of Responses:

1. Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the second anniversary of the vest date.

2. Includes DRSUs.

3. Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.

4. The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027.

5. The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.

Remarks:

This Form 4 reports (i) the acquisition by the reporting person of DRSUs resulting from an annual grant to the registrant's non-executive directors, (ii) a grant of RSUs to non-executive directors of Raymond James Bank, a subsidiary of registrant, (iii) a grant of RSUs to non-executive directors of TriState Capital Bank, a subsidiary of registrant, and (iv) the vesting of RSUs awarded to the reporting person.

	/s/ Cecily Mistarz by Jonathan J. Doyle as Attorney-in-Fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Cecily Mistarz report for RJF on this Form 4?

Cecily Mistarz reported acquiring Restricted Stock Units and common stock of RAYMOND JAMES FINANCIAL INC (RJF) on 2026-02-19. The filing shows equity grants and exercises of RSU awards as part of her compensation for service on the company’s Board of Directors.

How many RJF common shares were granted to Cecily Mistarz as part of Board compensation?

The Form 4 shows Cecily Mistarz received a grant of 1,303 shares of RJF common stock on 2026-02-19. This award is described as part of her compensation for serving on the Board of Directors and was reported at a price of $0.0000 per share.

What are Deferred Restricted Stock Units (DRSUs) in the RJF filing for Cecily Mistarz?

The filing explains DRSUs are Deferred Restricted Stock Units granted as Board compensation. Upon vesting, each converts into one RJF common share plus accrued cash in lieu of dividends, with vesting at the next annual shareholders meeting and settlement deferred two years after vesting under her election.

When do Cecily Mistarz’s RJF DRSU and RSU awards vest and settle?

The DRSUs vest at the next succeeding annual shareholders meeting following grant, but no later than March 15 of the following year. Under an irrevocable election, settlement of these DRSUs occurs on the second anniversary of the vest date, delaying delivery of shares and cash until that time.

How are RJF Restricted Stock Units described in Cecily Mistarz’s Form 4?

Each RJF Restricted Stock Unit represents a contingent right to receive one share of common stock and accrued cash in lieu of dividends upon vesting. Awards vest at the next annual shareholders meeting or by March 15, 2027, depending on the specific grant terms disclosed in the footnotes.

Did Cecily Mistarz’s RJF Form 4 include exercises of derivative securities?

Yes. Several transactions coded M reflect exercises or conversions of RSU derivative securities into RJF common stock at a reported price of $0.0000 per share. These include conversions of 1,253, 250, and another 250 Restricted Stock Units into corresponding common shares under the plan terms.